Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam Sedation on HRV After CABG
NCT03601091Unknown
- Sponsor
- Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi
- Start
- Mar 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in sedation (2 arms), sponsored by Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi. Primary endpoint: Heart Rate Variability at 24 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT03601091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03601091.